We are live on ! Find out more
CGA

Crescent Grove Advisors Portfolio holdings

AUM $1.04B
1-Year Est. Return 17.78%
This Fund
S&P 500
This Quarter Est. Return
+5.37%
1 Year Est. Return
+17.78%
3 Year Est. Return
+51.16%
5 Year Est. Return
+28.04%
10 Year Est. Return
–
AUM
$951M
AUM Growth
+$97.6M
Cap. Flow
+$55.9M
Cap. Flow %
5.88%
Top 10 Hldgs %
53.44%
Holding
271
New
61
Increased
90
Reduced
50
Closed
9

Top Buys

Rank Stock Value
1
VTI icon
Vanguard Total Stock Market ETF
VTI
+$7.48M
2
AAPL icon
Apple
AAPL
+$4.75M
3
ITOT icon
iShares Core S&P Total US Stock Market ETF
ITOT
+$4.63M
4
BKI
Black Knight, Inc. Common Stock
BKI
+$3.35M
5
IJS icon
iShares S&P Small-Cap 600 Value ETF
IJS
+$2.97M

Top Sells

Rank Stock Value
1
DNB
Dun & Bradstreet
DNB
+$4.81M
2
VYX icon
NCR Voyix
VYX
+$3.45M
3
GDRX icon
GoodRx Holdings
GDRX
+$1.72M
4
FIS icon
Fidelity National Information Services
FIS
+$1.41M
5
ARKF icon
ARK Blockchain & Fintech Innovation ETF
ARKF
+$1.31M

Sector Composition

Rank Sector Weight
1 Technology 38.13%
2 Industrials 8.21%
3 Consumer Discretionary 6.76%
4 Financials 3.95%
5 Healthcare 1.36%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
IWS icon
226
iShares Russell Mid-Cap Value ETF
IWS
$15.8B
$249K 0.03%
2,168
– –
CPRT icon
227
Copart
CPRT
$28.4B
$248K 0.03%
+7,520
New +$233K
GNR icon
228
State Street SPDR S&P Global Natural Resources ETF
GNR
$4.73B
$247K 0.03%
+4,656
New +$250K
APPH
229
DELISTED
AppHarvest, Inc. Common Stock
APPH
$247K 0.03%
+15,428
New +$246K
CCI icon
230
Crown Castle
CCI
$33.1B
$236K 0.02%
1,212
+48
+4% +$8.99K
VRTX icon
231
Vertex Pharmaceuticals
VRTX
$124B
$233K 0.02%
+1,157
New +$242K
CRM icon
232
Salesforce
CRM
$148B
$231K 0.02%
945
-180
-16% -$41.5K
ACWX icon
233
iShares MSCI ACWI ex US ETF
ACWX
$11.3B
$228K 0.02%
3,956
– –
VO icon
234
Vanguard Mid-Cap ETF
VO
$107B
$226K 0.02%
+3,808
New +$221K
MCD icon
235
McDonald's
MCD
$193B
$225K 0.02%
974
+27
+3% +$6.28K
CSGP icon
236
CoStar Group
CSGP
$12.4B
$224K 0.02%
+2,700
New +$233K
TM icon
237
Toyota
TM
$220B
$222K 0.02%
+1,270
New +$208K
PGR icon
238
Progressive
PGR
$128B
$221K 0.02%
+2,250
New +$223K
CLX icon
239
Clorox
CLX
$12.2B
$218K 0.02%
1,213
+113
+10% +$20.6K
ICE icon
240
Intercontinental Exchange
ICE
$86.3B
$217K 0.02%
+1,825
New +$210K
HII icon
241
Huntington Ingalls Industries
HII
$11.7B
$213K 0.02%
1,012
-910
-47% -$194K
CRSP icon
242
CRISPR Therapeutics
CRSP
$4.66B
$211K 0.02%
+1,304
New +$159K
ATVI
243
DELISTED
Activision Blizzard
ATVI
$211K 0.02%
+2,209
New +$209K
TXN icon
244
Texas Instruments
TXN
$254B
$209K 0.02%
+1,086
New +$204K
OSH
245
DELISTED
Oak Street Health, Inc.
OSH
$208K 0.02%
+3,550
New +$211K
MRNA icon
246
Moderna
MRNA
$22B
$207K 0.02%
+880
New +$157K
ABT icon
247
Abbott
ABT
$187B
$204K 0.02%
1,763
+74
+4% +$8.63K
CRWD icon
248
CrowdStrike
CRWD
$186B
$204K 0.02%
+3,240
New +$174K
NEM icon
249
Newmont
NEM
$96.5B
$204K 0.02%
+3,214
New +$215K
VEEV icon
250
Veeva Systems
VEEV
$32.6B
$204K 0.02%
+655
New +$183K
7 8 9
10
11

Similar funds

CCP
Clough Capital Partners Boston, Massachusetts $1.04B AUM 49.7% 1-Year Est. Return
SM
Scoggin Management New York $1.04B AUM 232.32% 1-Year Est. Return
NG
Norden Group Provo, Utah $1.04B AUM 23.49% 1-Year Est. Return
RC
RDST Capital Seattle, Washington $1.04B AUM 0.4% 1-Year Est. Return
OPFM
Optimus Prime Fund Management Grand Cayman, Cayman Islands $1.04B AUM 9.64% 1-Year Est. Return
NFG
Nadler Financial Group Deerfield, Illinois $1.04B AUM 19.04% 1-Year Est. Return
MSIIA
Morgan Stanley Institutional Investment Advisors Greenwood Village, Colorado $1.04B AUM 22.76% 1-Year Est. Return
CA
Continuum Advisory Eagle, Idaho $1.04B AUM 21.13% 1-Year Est. Return

Crescent Grove Advisors's Q2 2021 Portfolio in Review

As of Q2 2021, Crescent Grove Advisors held 271 positions worth $951M, up 11% from $853M the previous quarter. Its ten largest holdings account for 53% of the portfolio.

Crescent Grove Advisors deployed $55.9M of net new capital in Q2 2021, opening 61 new positions and adding to 90 existing holdings. Its largest new stake was iShares 1-5 Year Investment Grade Corporate Bond ETF: 38,389 shares worth $2.1M.

By sector, the portfolio is most concentrated in Technology at 38% of assets, down from 40% a quarter earlier, followed by Industrials and Consumer Discretionary.

On the sell side, the largest reduction was Dun & Bradstreet, an estimated $4.81M trimmed.

  • Crescent Grove Advisors's largest Q2 2021 buy was iShares 1-5 Year Investment Grade Corporate Bond ETF: 38,389 shares worth $2.1M.
  • Crescent Grove Advisors added most to Vanguard Total Stock Market ETF in Q2 2021, an estimated $7.48M increase.
  • Crescent Grove Advisors's biggest Q2 2021 reduction was Dun & Bradstreet, cutting an estimated $4.81M.
  • Crescent Grove Advisors fully exited GoodRx Holdings in Q2 2021, selling an estimated $1.72M.
  • Crescent Grove Advisors's ten largest holdings make up 53% of its $951M portfolio in Q2 2021.
  • Crescent Grove Advisors opened 61 new positions and closed 9 in Q2 2021.
  • Crescent Grove Advisors's portfolio value rose 11% quarter-over-quarter to $951M.

Based on Crescent Grove Advisors's 13F filing for Q2 2021, filed 26 Jul 2021.